GTG 0.00% 4.5¢ genetic technologies limited

Ann: New Product Announcement, page-127

  1. 20,450 Posts.
    lightbulb Created with Sketch. 269

    once they sign a distribution deal would expect a massive rerate, from lastest announcement expected in coming months:

    Commercialisation and Product Distribution Plans:

    GTG intends to introduce the new ‘GeneType for Colorectal Cancer’ and ‘GeneType for Breast Cancer’genetic tests to healthcare providers through a global network of distribution partners. The Company hasalready announced it is working with TGen in the United States and also Chinese partners connected to theHainan Free-Trade Zone. More announcements are anticipated in this regard in coming months as GTG movesto commercialise its suite of world-leading genetic tests.
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
0.000(0.00%)
Mkt cap ! $6.543M
Open High Low Value Volume
4.5¢ 4.5¢ 4.5¢ $35 767

Buyers (Bids)

No. Vol. Price($)
1 82854 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.7¢ 25037 2
View Market Depth
Last trade - 10.04am 24/07/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.